These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 11160623)
1. Pharmacokinetics and immunological effects of exogenously administered recombinant human B lymphocyte stimulator (BLyS) in mice. Parry TJ; Riccobene TA; Strawn SJ; Williams R; Daoud R; Carrell J; Sosnovtseva S; Miceli RC; Poortman CM; Sekut L; Li Y; Fikes J; Sung C J Pharmacol Exp Ther; 2001 Feb; 296(2):396-404. PubMed ID: 11160623 [TBL] [Abstract][Full Text] [Related]
2. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice. Riccobene TA; Miceli RC; Lincoln C; Knight Y; Meadows J; Stabin MG; Sung C J Nucl Med; 2003 Mar; 44(3):422-33. PubMed ID: 12621010 [TBL] [Abstract][Full Text] [Related]
3. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291 [TBL] [Abstract][Full Text] [Related]
4. [The immunopotentiation of human B lymphocyte stimulator C-terminal peptide]. Tian RY; Han W; Yu Y; Chen Y; Yu GS; Yang SL; Gong Y Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1128-32. PubMed ID: 14673506 [TBL] [Abstract][Full Text] [Related]
5. Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse. Cambridge G; Stohl W; Leandro MJ; Migone TS; Hilbert DM; Edwards JC Arthritis Rheum; 2006 Mar; 54(3):723-32. PubMed ID: 16508933 [TBL] [Abstract][Full Text] [Related]
6. Immunological effects of refolded human soluble BAFF synthesized in Escherichia coli on murine B lymphocytes in vitro and in vivo. Cao M; Chen L; Shan XX; Zhang SQ Jpn J Physiol; 2005 Aug; 55(4):221-7. PubMed ID: 16255842 [TBL] [Abstract][Full Text] [Related]
7. Control of spontaneous B lymphocyte autoimmunity with adenovirus-encoded soluble TACI. Liu W; Szalai A; Zhao L; Liu D; Martin F; Kimberly RP; Zhou T; Carter RH Arthritis Rheum; 2004 Jun; 50(6):1884-96. PubMed ID: 15188365 [TBL] [Abstract][Full Text] [Related]
8. Construction and function of two Cys146-mutants with high activity, derived from recombinant human soluble B lymphocyte stimulator. Chen G; Peng S; Zou M; Xu H; Xu D; Wang J J Biochem; 2004 Jul; 136(1):73-9. PubMed ID: 15269242 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Cheema GS; Roschke V; Hilbert DM; Stohl W Arthritis Rheum; 2001 Jun; 44(6):1313-9. PubMed ID: 11407690 [TBL] [Abstract][Full Text] [Related]
10. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA. Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217 [TBL] [Abstract][Full Text] [Related]
12. The anti-apoptotic factor Bcl-2 can functionally substitute for the B cell survival but not for the marginal zone B cell differentiation activity of BAFF. Tardivel A; Tinel A; Lens S; Steiner QG; Sauberli E; Wilson A; Mackay F; Rolink AG; Beermann F; Tschopp J; Schneider P Eur J Immunol; 2004 Feb; 34(2):509-18. PubMed ID: 14768056 [TBL] [Abstract][Full Text] [Related]
13. Optimization of BLyS production and purification from Escherichia coli. Laird MW; Sampey GC; Johnson K; Zukauskas D; Pierre J; Hong JS; Cooksey BA; Li Y; Galperina O; Karwoski JD; Burke RN Protein Expr Purif; 2005 Feb; 39(2):237-46. PubMed ID: 15642475 [TBL] [Abstract][Full Text] [Related]
15. The uncertain glory of APRIL. Medema JP; Planelles-Carazo L; Hardenberg G; Hahne M Cell Death Differ; 2003 Oct; 10(10):1121-5. PubMed ID: 14502235 [TBL] [Abstract][Full Text] [Related]
16. Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome. Gottenberg JE; Busson M; Cohen-Solal J; Lavie F; Abbed K; Kimberly RP; Sibilia J; Mariette X Ann Rheum Dis; 2005 Jul; 64(7):1050-5. PubMed ID: 15640273 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice. Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346 [TBL] [Abstract][Full Text] [Related]
18. Chronic administration of belimumab, a BLyS antagonist, decreases tissue and peripheral blood B-lymphocyte populations in cynomolgus monkeys: pharmacokinetic, pharmacodynamic, and toxicologic effects. Halpern WG; Lappin P; Zanardi T; Cai W; Corcoran M; Zhong J; Baker KP Toxicol Sci; 2006 Jun; 91(2):586-99. PubMed ID: 16517838 [TBL] [Abstract][Full Text] [Related]